Figure 2.
Vaccine efficacy against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, displayed as cumulative SARS-CoV-2 incidence by group, among baseline SARS-CoV-2–negative participants.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.